These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28294731)

  • 41. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
    Touyz RM; Schiffrin EL
    J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome.
    Chen MC; Hsu BG; Lee CJ; Yang CF; Wang JH
    Clin Chim Acta; 2017 Oct; 473():166-172. PubMed ID: 28860092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet aggregation and the volume distribution of platelets in spontaneously hypertensive rats.
    Yamori Y; Ohta K; Horie R; Ohtaka M; Ooshima A
    Jpn Heart J; 1978 Jul; 19(4):575-6. PubMed ID: 731887
    [No Abstract]   [Full Text] [Related]  

  • 44. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
    Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
    Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low serum long-acting natriuretic peptide level correlates with metabolic syndrome in hypertensive patients: a cross-sectional study.
    Hsieh JC; Wang JH; Lee CJ; Chen YC; Liou HH; Hsu BG
    Arch Med Res; 2013 Apr; 44(3):215-20. PubMed ID: 23506722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for altered platelet nitric oxide synthesis in essential hypertension.
    Cadwgan TM; Benjamin N
    J Hypertens; 1993 Apr; 11(4):417-20. PubMed ID: 8390509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood platelets in human essential hypertension.
    De Clerck F
    Agents Actions; 1986 Aug; 18(5-6):563-80. PubMed ID: 3532721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of taurine on calcium in platelets and their aggregation.
    Elizarova EP
    Adv Exp Med Biol; 1996; 403():589-95. PubMed ID: 8915398
    [No Abstract]   [Full Text] [Related]  

  • 49. [The state of hemostatic system and platelet metabolism in patients with complicated hypertensive disease].
    Shimokhina NIu; Petrova MM; Savchenko AA; Smertina EG
    Klin Med (Mosk); 2010; 88(3):31-5. PubMed ID: 20608061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance.
    Schneider DJ
    Coron Artery Dis; 2005 Dec; 16(8):473-6. PubMed ID: 16319656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The condition of vascular-thrombocyte hemostasis in the elderly with arterial hypertension].
    Nosov VP; Borovkov NN; Bashiukova OG
    Klin Med (Mosk); 2005; 83(12):32-6. PubMed ID: 16502721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
    Craveri A; Lanfredini M; Casati R; Citella C
    Minerva Med; 1988 Jun; 79(6):441-6. PubMed ID: 2967926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The influence of nebivolol on thrombocyte aggregation in patients with arterial hypertension with metabolic sydrome].
    Medvedev IN; Gromnatsiĭ NI
    Klin Med (Mosk); 2005; 83(3):31-3. PubMed ID: 15881638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of polyunsaturated/saturated fatty acids to metabolic syndrome cardiovascular risk factors and lipoprotein (a) in hypertensive type 2 diabetic patients.
    Bennacer AF; Haffaf E; Kacimi G; Oudjit B; Koceir EA
    Ann Biol Clin (Paris); 2017 Jun; 75(3):293-304. PubMed ID: 28540852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship of platelet specific proteins and other factors to atherosclerosis in various stages of hypertension.
    Ding YA; Chou TC; Huan R; Lin KC
    Clin Exp Hypertens A; 1991; 13(8):1329-41. PubMed ID: 1836985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Various aspects of blood platelet activity in arterial hypertension].
    Berent H; Kuczyńska K
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):727-31. PubMed ID: 2534931
    [No Abstract]   [Full Text] [Related]  

  • 58. Microparticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components.
    Agouni A; Andriantsitohaina R; Martinez MC
    Curr Vasc Pharmacol; 2014 May; 12(3):483-92. PubMed ID: 24846237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of enalapril maleate on vascular endothelial function and platelet-endothelial interactions in patients with essential hypertension].
    Iakovlev VM; Semenkin AA; Iudin SM; Nazarov AG; Kudriashov IL; Potapov VV; Korennova OIu; Il'iunykh LN
    Ter Arkh; 2000; 72(1):40-4. PubMed ID: 10687205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of dietary sodium on platelet alpha 2-adrenergic receptors in essential hypertension.
    Ashida T; Tanaka T; Yokouchi M; Kuramochi M; Deguchi F; Kimura G; Kojima S; Ito K; Ikeda M
    Hypertension; 1985; 7(6 Pt 1):972-8. PubMed ID: 3000938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.